Oscar Health (OSCR) Stock Price, News & Analysis

Company Overview

Oscar Health, Inc. is a technology-driven health insurance company that provides health plans and related services to individuals, families and businesses in the United States. The company primarily serves members through plans offered under the Affordable Care Act (ACA), including individual and family coverage purchased through government marketplaces.

Oscar’s offerings include medical insurance plans with access to provider networks, prescription drug coverage and member support services. Its technology platform is designed to help members search for care, manage benefits, communicate with care teams and navigate the health care system through digital tools and personalized assistance. Oscar has also offered coverage for small businesses and has participated in other government-sponsored health insurance programs at various times.

Oscar was founded in 2012 by Mario Schlosser, Kevin Nazemi and Josh Kushner, and went public on the New York Stock Exchange in 2021. The company has expanded its ACA marketplace presence across multiple states, although the specific states and products it serves may change as it updates its plan offerings. Mark Bertolini has served as Oscar Health’s chief executive officer since 2023, with co-founder Mario Schlosser continuing in a senior leadership role.

Key Stats

• Today's Range: $32.02 to $32.84
• 50-Day Range: $26.53 to $33.86
• 52-Week Range: $10.69 to $34.48
• Volume: 4.89 million shs
• Average Volume: 5.53 million shs
• Market Capitalization: $9.96 billion
• P/E Ratio: 23.05
• Dividend Yield: N/A
• Price Target: $33.90
• Consensus Rating: Hold

Oscar Health Stock Analysis - MarketRank™

Oscar Health scored higher than 85% of companies evaluated by MarketBeat, and ranked 70th out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Hold

Consensus Rating

Oscar Health has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 1 strong buy rating, 3 buy ratings, 8 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Oscar Health is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Oscar Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 21.31%

Earnings Growth

Earnings for Oscar Health are expected to grow by 21.31% in the coming year, from $1.83 to $2.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Oscar Health is 23.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.01.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oscar Health is 23.05, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.94.

Price to Earnings Growth Ratio

Oscar Health has a PEG Ratio of 0.36. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Oscar Health has a P/B Ratio of 9.81. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.44% of the float of Oscar Health has been sold short.

Short Interest Ratio / Days to Cover

Oscar Health has a short interest ratio ("days to cover") of 3.65, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Oscar Health has recently increased by 8.59%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oscar Health does not currently pay a dividend.

Dividend Growth

Oscar Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.70

News Sentiment

Oscar Health has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Oscar Health this week, compared to 6 articles on an average week.

Search Interest

17 people have searched for OSCR on MarketBeat in the last 30 days. This is an increase of 113% compared to the previous 30 days.

MarketBeat Follows

18 people have added Oscar Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Oscar Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $26,761,671.00 in company stock.

Percentage Held by Insiders

22.64% of the stock of Oscar Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

75.70% of the stock of Oscar Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/07/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NYSE:OSCR
• CIK: 1568651
• Web: www.hioscar.com
• Phone: 646-403-3677
• Fax: N/A
• Employees: 2,305
• Year Founded: 2012

Price Target and Rating

• Average Price Target for Oscar Health: $33.90
• High Price Target: $49.00
• Low Price Target: $16.00
• Potential Upside/Downside: +5.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.31
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.40
• Trailing P/E Ratio: 23.05
• Forward P/E Ratio: 17.63
• P/E Growth: 0.36
• Net Income: -$443.15 million
• Net Margins: 3.60%
• Pretax Margin: 3.85%
• Return on Equity: 38.45%
• Return on Assets: 6.76%

Debt

• Debt-to-Equity Ratio: 0.21
• Current Ratio: 1.09
• Quick Ratio: 1.09

Sales & Book Value

• Annual Sales: $11.70 billion
• Price / Sales: 0.85
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.29 per share
• Price / Book: 9.81

Miscellaneous

• Outstanding Shares: 308,640,000
• Free Float: 238,768,000
• Market Cap: $9.96 billion
• Optionable: Optionable
• Beta: 2.47